Clinical Trials Logo

Mammoplasty clinical trials

View clinical trials related to Mammoplasty.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04331080 Completed - Clinical trials for Breast Reconstruction

A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

Start date: July 1, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate effectiveness of Granexin® gel in reducing scar formation in surgical incisional wounds.

NCT ID: NCT03744013 Completed - Mammoplasty Clinical Trials

A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis

APPeaR
Start date: May 7, 2019
Phase: N/A
Study type: Interventional

This is a post market prospective, multi-center study of up to 100 subjects undergoing post-mastectomy breast reconstruction (50 Fortiva® 1mm perforated and 50 Fortiva® 1mm non-perforated) at up to 10 clinical study sites in Europe.

NCT ID: NCT03213249 Completed - Mammoplasty Clinical Trials

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

Start date: July 25, 2017
Phase: Phase 1
Study type: Interventional

Breast implants, either cosmetic or reconstructive, are among the most common procedures performed by plastic surgeons. Bacterial infections or biofilms are implicated in the majority of breast implant complications including infection requiring explantation, capsular contracture (CC), and/or breast-implant associated anaplastic large cell lymphoma (BIA-ALCL). The research team, which has already extensively characterized bacterial pathogenesis in the urinary tract and designed non-antibiotic therapeutics to reduce the incidence of catheter-associated urinary tract infections (CAUTIs), and proposal will study bacteria-breast implant interactions and explore further the impact of the breast microbiome. The proposed research provides a greater understanding of which bacteria can colonize breast implants, their source, and how effective antibiotic pocket irrigation is at eliminating them, and begins to examine the mechanisms by which bacteria bind and colonize the implant surface. These insights will set the groundwork for developing new therapeutic agents that can disrupt the binding of certain bacteria to breast implants. Strategies that minimize problems bacteria can cause, while avoiding antibiotics, will reduce bacteria-related implant complications, limit antibiotic-related side effects, and reduce bacterial resistance.

NCT ID: NCT01582490 Completed - Postoperative Pain Clinical Trials

Study of EXPAREL in Patients Undergoing Breast Augmentation

Start date: April 2012
Phase: Phase 4
Study type: Interventional

This is a Phase 4, prospective, open-label, non-randomized, sequential study with two treatment groups differing only in the technique used for EXPAREL administration (instillation or infiltration).

NCT ID: NCT00505557 Completed - Mammoplasty Clinical Trials

Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope

Start date: May 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the feasibility and outcome of performing dual plane breast augmentation with assistant of endoscope by axillary approach.